Starbucks Corporation (NASDAQ: SBUX) is slated to report fourth quarter 2019 earnings results on Wednesday, October 30, after the market closes. Analysts have projected earnings of $0.70 per share, which is higher than the $0.62 reported a year earlier. Sales is also expected to increase 6% year-over-year to $6.6 billion.
The quarterly results are likely to benefit from strong comparable store sales growth as well as strength in the Americas and China/Asia-Pacific regions. Last quarter, global comp sales rose 6%, helped by increases in average ticket and comparable transactions.
The company’s loyalty program, digital capabilities and strategic partnerships are also expected to help drive growth in the quarter. Starbucks’ addition of new stores will aid in expanding its footprint and boosting results. The company has targeted around 2,000 new store openings in 2019.
However, the weakness seen in the EMEA and Channel Development segments is expected to continue in the fourth quarter as well. Starbucks also faces stiff competition from Luckin Coffee (NASDAQ: LK) and Coca-Cola’s (NYSE: KO) Costa Coffee.
Also read: Starbucks Q3 2019 Earnings Conference Call Transcript
In the third quarter of 2019, Starbucks topped revenue and earnings expectations. Revenue grew 8% year-over-year to $6.8 billion while adjusted EPS rose 26% to $0.78.
For fiscal year 2019, Starbucks has guided for revenue growth of around 7% with global comparable store sales growth of about 4%. The company expects GAAP EPS of $2.86 to $2.88 and adjusted EPS of $2.80 to $2.82.
Last month, the stock saw a dip due to a weaker-than-expected earnings forecast for fiscal year 2020. Starbucks expects FY20 EPS to be below its ongoing growth model of 10%.
Starbucks’ shares have gained 22% thus far this year. The stock was trading in positive territory during afternoon hours on Monday.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
